[go: up one dir, main page]

AU2001260627A1 - Drug composition antagonistic to both pgd2/txa2 receptors - Google Patents

Drug composition antagonistic to both pgd2/txa2 receptors

Info

Publication number
AU2001260627A1
AU2001260627A1 AU2001260627A AU6062701A AU2001260627A1 AU 2001260627 A1 AU2001260627 A1 AU 2001260627A1 AU 2001260627 A AU2001260627 A AU 2001260627A AU 6062701 A AU6062701 A AU 6062701A AU 2001260627 A1 AU2001260627 A1 AU 2001260627A1
Authority
AU
Australia
Prior art keywords
pgd2
drug composition
antagonistic
txa2
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001260627A
Inventor
Akinori Arimura
Norihiko Tanimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU2001260627A1 publication Critical patent/AU2001260627A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001260627A 2000-06-02 2001-05-28 Drug composition antagonistic to both pgd2/txa2 receptors Abandoned AU2001260627A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-166305 2000-06-02
JP2000166305 2000-06-02
PCT/JP2001/004430 WO2001094309A1 (en) 2000-06-02 2001-05-28 Drug composition antagonistic to both pgd2/txa2 receptors

Publications (1)

Publication Number Publication Date
AU2001260627A1 true AU2001260627A1 (en) 2001-12-17

Family

ID=18669644

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001260627A Abandoned AU2001260627A1 (en) 2000-06-02 2001-05-28 Drug composition antagonistic to both pgd2/txa2 receptors

Country Status (5)

Country Link
US (1) US7084136B2 (en)
EP (1) EP1295872A4 (en)
JP (1) JPWO2001094309A1 (en)
AU (1) AU2001260627A1 (en)
WO (1) WO2001094309A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1194418A1 (en) 1999-06-21 2002-04-10 Boehringer Ingelheim Pharma KG Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof
WO2002036583A1 (en) 2000-11-01 2002-05-10 Shionogi & Co., Ltd. Pgd2 receptor antagonistic pharmaceutical compositions
US7019012B2 (en) * 2000-12-20 2006-03-28 Boehringer Ingelheim International Pharma Gmbh & Co. Kg Quinazoline derivatives and pharmaceutical compositions containing them
AR039280A1 (en) * 2002-04-11 2005-02-16 Smithkline Beecham Corp AMINOTIOFEN COMPOUND AND ITS USE TO PREPARE A PHARMACEUTICAL COMPOSITION
DE10221018A1 (en) * 2002-05-11 2003-11-27 Boehringer Ingelheim Pharma Use of inhibitors of EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH) / prostatic hypertrophy
CA2511214C (en) 2002-12-20 2012-12-18 Tularik, Inc. Asthma and allergic inflammation modulators
US7223749B2 (en) * 2003-02-20 2007-05-29 Boehringer Ingelheim International Gmbh Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
DE602005006539D1 (en) 2004-03-11 2008-06-19 Actelion Pharmaceuticals Ltd TETRAHYDROPYRIDOINDOLDERIVATE
EP1794157B1 (en) 2004-09-22 2014-02-26 H. Lundbeck A/S 2-acylaminothiazole derivatives
US7674912B2 (en) 2005-04-25 2010-03-09 H. Lundbeck A/S Pro-drugs of N-thiazol-2-yl-benzamide derivatives
CA2629244C (en) 2005-11-11 2014-08-05 Boehringer Ingelheim International Gmbh Quinazoline derivatives for the treatment of cancer diseases
SI2068880T1 (en) * 2006-09-18 2012-08-31 Boehringer Ingelheim Int Method for treating cancer harboring egfr mutations
US8183293B2 (en) 2007-12-19 2012-05-22 Amgen Inc. Phenyl acetic acid derivatives
DK2451445T3 (en) 2009-07-06 2019-06-24 Boehringer Ingelheim Int PROCEDURE FOR DRYING BIBW2992, IT'S SALTS AND SOLID PHARMACEUTICAL FORMULATIONS INCLUDING THIS ACTIVE INGREDIENT
US9242965B2 (en) 2013-12-31 2016-01-26 Boehringer Ingelheim International Gmbh Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
MX2024010565A (en) 2022-03-02 2024-09-06 Horizon Therapeutics Ireland Dac Process of making a crystalline edg-2 receptor antagonist.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4037941A1 (en) 1990-11-23 1992-05-27 Schering Ag CYCLOPENTANETHER DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE
DE4225488A1 (en) 1992-07-30 1994-02-03 Schering Ag New bi:cyclooctane carbacyclin analogues - useful as thromboxane A2 and prostaglandin H2 antagonists
KR100428601B1 (en) * 1995-06-21 2004-09-16 시오노기세이야쿠가부시키가이샤 Bicyclic amino derivatives and prostaglandin di 2 antagonists containing them
US6225336B1 (en) * 1997-09-19 2001-05-01 Shionogi & Co., Ltd. Compounds having [2.2.1] bicyclo skeleton
WO2000030683A1 (en) * 1998-11-19 2000-06-02 Shionogi & C0., Ltd. Preventives and/or remedies for central nervous system diseases containing compounds having txa2 receptor antagonism and/or txa2 synthase inhibitory effect
JP3828364B2 (en) * 1999-03-10 2006-10-04 塩野義製薬株式会社 [2.2.1] and [3.1.1] PGD2 / TXA2 Receptor Antagonistic Pharmaceutical Composition Having Bicyclo Skeleton

Also Published As

Publication number Publication date
EP1295872A1 (en) 2003-03-26
JPWO2001094309A1 (en) 2004-02-05
WO2001094309A1 (en) 2001-12-13
US7084136B2 (en) 2006-08-01
US20040024019A1 (en) 2004-02-05
EP1295872A4 (en) 2007-05-16

Similar Documents

Publication Publication Date Title
AU2001296013A1 (en) Pgd2 receptor antagonistic pharmaceutical compositions
AU2001260627A1 (en) Drug composition antagonistic to both pgd2/txa2 receptors
AU781269C (en) Pharmaceutical compositions
AU2002210782A1 (en) Amide derivatives as nmda receptor antagonists
AU2001250205A1 (en) Prostaglandin d2 receptor antagonists
AU2001274307A1 (en) Pharmaceutical compositions
AU2001264657A1 (en) Crf receptor antagonists
AU2001264264A1 (en) Sustained release compositions
AU2002221115A1 (en) Medicinal compositions having improved absorbability
AU2001248772A1 (en) Sustained release drug compositions
AU2001273919A1 (en) Pharmaceutical compositions
AU2001295455A1 (en) Indoline derivatives as 5ht2c antagonists
AU2001240097A1 (en) G protein-coupled receptors
AU2002239291A1 (en) G protein coupled receptors
AU2001263288A1 (en) Crf receptor antagonists
EP1286673B8 (en) Ligands of integrin receptors
AU2001230594A1 (en) Novel scavenger receptors
AU2001249922A1 (en) G protein-coupled receptors
AU2001266143A1 (en) Delivery of bronchially provocative agents
AU2001259322A1 (en) G protein-coupled receptors
AU2001275238A1 (en) Deformable gravel pack
AU2001238682A1 (en) Human g protein-coupled receptors
AU2002346030A1 (en) Novel receptors
AU2001257231A1 (en) Novel g protein-coupled receptors
WO2002077001A9 (en) Novel receptors